Universitaetsmedizin Goettingen

Cardiovascular disease and heart failure

Research activity includes advanced heart failure, chronic right heart failure, and aortic stenosis with myocardial fibrosis. The portfolio also covers interventions linked to transcatheter aortic valve implantation and cardiac regeneration.

  • Heart failure and right ventricular dysfunction
  • Myocardial fibrosis and fibrotic burden
  • Cardiac imaging and structural heart disease

These studies reflect a strong interest in cardiometabolic and structural cardiac conditions with unmet treatment needs.

Kidney disease and genetic nephrology

The sponsor is active in chronic kidney disease linked to Alport syndrome, with emphasis on early renal preservation and inherited renal disorders. The research also addresses progression of kidney involvement in younger patients.

  • Alport syndrome
  • Chronic kidney disease
  • Renal protection and albuminuria

This area highlights involvement in rare kidney diseases and long-term preservation of renal function.

Oncology and neuroendocrine tumors

Clinical research includes neuroendocrine neoplasia, neuroendocrine tumor, and oligometastatic pancreatic cancer, with interest in both systemic and surgical treatment strategies. The oncology portfolio spans aggressive and advanced malignancies.

  • Neuroendocrine neoplasia
  • Pancreatic cancer
  • Multimodal cancer treatment

The sponsor’s oncology work focuses on difficult-to-treat tumors requiring coordinated medical and surgical care.

Neurometabolic and mitochondrial disorders

Research extends to Kearns-Sayre syndrome and related cerebral folate deficiency, indicating interest in rare mitochondrial disease and neurologic metabolic dysfunction. The portfolio also includes cognitive outcomes in systemic disease.

  • Kearns-Sayre syndrome
  • Mitochondrial disorders
  • Cognitive impairment

These studies link rare inherited disease with neurologic and functional outcomes.

Behavioral health and metabolic support

Additional activity covers binge eating disorder and the treatment of iron deficiency in people with chronic heart failure. This combines psychiatric symptom management with supportive care in chronic medical illness.

  • Binge eating disorder
  • Iron deficiency
  • Cognitive function and quality of life

The sponsor’s research interests include both mental health and systemic complications that affect daily functioning.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Hydrocortisone and Food Exposure Therapy for Patients with Binge Eating Disorder

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of Spironolactone and Dihydralazine for reducing heart muscle scarring in patients with severe aortic valve narrowing after valve replacement procedure

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of Cabozantinib in Adults with Advanced Low-Grade Neuroendocrine Tumors

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany